When was Arctic Bioscience founded?

Arctic Bioscience was founded in 2011 and raised its 1st funding round 8 years after it was founded.

Where is Arctic Bioscience located?

Arctic Bioscience is headquartered in Oslo, Norway.

Who is the current CEO of Arctic Bioscience?

Ole Arne Eiksund and Christer Valderhaug s of Arctic Bioscience.

How many employees does Arctic Bioscience have?

As of May 31, 2026, the latest employee count at Arctic Bioscience is 34.

Is Arctic Bioscience a funded company?

Arctic Bioscience is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Aug 01, 2019.

When was the latest funding round of Arctic Bioscience?

Arctic Bioscience's latest funding was a $***** Post IPO round on Feb 16, 2021, with participation from 0 investor.

Where does Arctic Bioscience rank among its competitors?

Arctic Bioscience ranks 6th amongst 30 active competitors, of which 5 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Rani Therapeutics, which secured $60.3M in Oct, 2025.

Who are the top competitors of Arctic Bioscience?

Arctic Bioscience's top competitors include Aclaris Therapeutics, Samsung Bioepis and Alumis. Among them, Rani Therapeutics secured the most recent funding round in October, 2025.

Arctic Bioscience - 2026 Company Profile, Team, Funding, Competitors & Financials

Arctic Bioscience is a public company based in Oslo (Norway), founded in 2011. It operates as a Developer of the drug for psoriasis. Arctic Bioscience has raised an undisclosed amount in funding. The company has 30 active competitors, including 5 funded and 10 that have exited. Its top competitors include companies like Aclaris Therapeutics, Samsung Bioepis and Alumis.

Company Details

Developer of the drug for psoriasis. The product HRO350 is a phospholipid drug for the oral treatment of psoriasis based on bioactive marine compounds extracted from herring roe. Also, have herring caviar oil and omega-3 dietary supplement Romega.

Website: www.arctic-bioscience.com/
Email ID: *****@arctic-bioscience.com
Phone Number: +47 **********

Key Metrics

Founded Year

2011

Location

Oslo, Norway

Stage

Public

Latest Funding Round

Post IPO, Feb 16, 2021, $*****

Investors

Europa & 1 more

Ranked

6^th among 30 active competitors

Employee Count

34 as on May 31, 2026

Similar Companies

Aclaris Therapeutics & 29 more

Exit Details

Public

View Arctic Bioscience's full profile

Arctic Bioscience is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ARCTIC BIOSCIENCE AS CIN: 996638812 , Norway, Active		-	13 (As on Dec 31, 2020)
Arctic Bioscience AS CIN: 996638812 , Norway, Active		-	-

Arctic Bioscience got listed on Feb 24, 2021.

Click here to take a look at Arctic Bioscience's IPO in detail

Arctic Bioscience has raised funding over 2 rounds. Its first funding round was on Aug 01, 2019. Arctic Bioscience has 2 institutional investors.

Here is the list of recent funding rounds of Arctic Bioscience:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 16, 2021	3694517	Post IPO	3915903	6284935	9315047	4459836
Aug 01, 2019	3895585	Grant (prize money)	4361144	6768068	6859606	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Arctic Bioscience's funding rounds and investors

Arctic Bioscience's employee count trend

Arctic Bioscience has 34 employees as of May 26. Here is Arctic Bioscience's employee count trend over the years:

Employee count trend for Arctic Bioscience

Uncover Arctic Bioscience's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Arctic Bioscience include Aclaris Therapeutics, Samsung Bioepis and Alumis. Here is the list of Top 10 competitors of Arctic Bioscience, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Aclaris Therapeutics 2012, Malvern (United States), Public	Biopharmaceutical company empowering patients through therapeutic innovation in immuno-inflammatory conditions	$82M	Vivo Capital, RA Capital Management & 13 others	65/100
2nd	Samsung Bioepis 2012, Incheon (South Korea), Acquired	Developer of biosimilar drugs for the treatment of multiple diseases	-	Biogen, Samsung BioLogics	64/100
3rd	Alumis 2003, San Francisco (United States), Public	Developer of therapeutics for the treatment of auto-immune disease	$529M	Foresite Capital, Samsara BioCapital & 13 others	62/100
4th	Rani Therapeutics 2012, San Jose (United States), Public	Developer of technology for the oral delivery of large drug molecules	$226M	Shire, Cathay Financial Holdings & 18 others	61/100
5th	Affibody 1998, Solna (Sweden), Series D	Developer of antibody mimetic and protein based drug for the treatment of multiple diseases	$43.3M	AP3, Stena Sessan & 9 others	56/100
6th	Arctic Bioscience 2011, Oslo (Norway), Public	Developer of the drug for psoriasis	-	Europa, Aleap	44/100
7th	DICE 2013, San Francisco (United States), Acquired	Developer of small molecule therapeutics for multiple disorders	$192M	RA Capital Management, Sands Capital Ventures ... & 17 others	48/100
8th	Soligenix 1987, Princeton (United States), Public	Developer of small molecule therapeutics for rare disease therapies	-	New Jersey Economic Development Authority, Kodiak Capital ... & 14 others	47/100
9th	MoonLake 2021, Zug (Switzerland), Public	Developer of immunotherapies for inflammatory skin and joint diseases	-	-	42/100
10th	Avro Lifesciences 2016, Waterloo (Canada), Seed	Developer of dermal therapies and patches for pediatric use	$150K	Fifty Years, Accelerator Centre & 14 others	42/100